European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Genome Research Ltd., Saffron Walden

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Genome Research Ltd.
Wellcome Trust Sanger Institute

Register

Chp
Companies House 02742969

Address

Hinxton, THE Sanger Centre, Wellcome Trust Genome Campus, Saffron Walden CB10 1SA, United Kingdom
London, United Kingdom

Corporate purpose

A) to Advance Research Into and Investigation of the Human Genome and to Publish the Useful Results of Such Research B) to Advance Scientific and Medical Research

Additional info

72.11
Research and experimental development on biotechnology

Financials

History

Marketing & Tech

Network

Loading network
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Publications

10 Jun 2024
Director: John-Arne Røttingen · No longer Director: Paul J. R. Schreier
17 May 2024
Director: Michael Dunn
29 Apr 2024
No longer Director: Cheryl Anne Moore
23 Apr 2024
Director: Karen Chadwick
22 Apr 2024
Director: Mark Mccarthy, M. Newcombe-Ellis, Caroline Relton
10 Apr 2024
Patent: Bacteriotherapy
26 Mar 2024
No longer Director: Gilean Mcvean
14 Mar 2024
Director's details changed for Cheryl Anne Moore
12 Mar 2024 also 13/02/2023, 11/03/2022, 22/03/2021, 10/01/2020, 25/01/2019, 29/12/2017, 21/12/2016, 19/01/2016, 16/01/2015, 31/12/2013, 22/01/2013, 12/01/2012, 23/12/2010, 06/01/2010, 27/01/2009, 22/12/2007, 10/01/2007, 17/01/2006, 25/04/2005
Full accounts made up to 2023-09-30
8 Feb 2024
Reg­is­tra­tion: 21/05/1993 · Chair: Paul Schreier · Board: Cilla Snowball, Daniel Abrams, Nicole Mather · Email · Legal form: Charitable company · Phone Number · Corporate Purpose · Website
7 Feb 2024
Annual report for the year ending 30/09/2023 · Earnings statement for 30/09/2023 · 1,271 employees
5 Jul 2023 also 07/07/2022, 02/07/2021, 10/07/2020, 27/06/2019, 02/07/2018, 28/06/2017
Confirmation statement made with no updates
7 Jun 2023
Patent: Method for Sequencing a Direct Repeat
10 May 2023
Address
17 Mar 2023 also 19/12/2017
Termination of appointment of Kay Elizabeth Davies as a director
7 Mar 2023
No longer Director: Jeremy Farrar
12 Jan 2023
Annual report for the year ending 30/09/2022 · Earnings statement for 30/09/2022 · 1,187 employees
21 Mar 2022
Annual report for the year ending 30/09/2021 · Earnings statement for 30/09/2021 · 1,178 employees
24 Nov 2021
Patent: Methods for the Accurate Detection of Mutations in Single Molecules of DNA
23 Sept 2021
Patent: Biomarkers
26 Aug 2021
Director: Cilla Snowball
22 Jul 2021
Termination of appointment of James Cuthbert Smith as a director
Year 2021 in Hor
4 EU fundings (€212,934): Building a reproducible single-cell experimental workflow to capture tumour cell persistence …
25 Jun 2021
Patent: Culture of Organoids
25 Jan 2021
Annual report for the year ending 30/09/2020 · Earnings statement for 30/09/2020 · 1,055 employees
Year 2020 in Hor
6 EU fundings (€653,316): European Network Linking Informatics and Genomics of Helper T cells in Tissues …
Year 2020 in Epobase
6 European patent filings: Bacterial Compositions for the Treatment of Disease …
1 Jun 2020
Director's details changed for Dr Daniel Mahony
21 May 2020
Director: Daniel Mahony, Gilean Mcvean, Cheryl Anne Moore · No longer Director: Rolf Dieter Heuer
13 May 2020
Annual report for the year ending 30/09/2019 · Earnings statement for 30/09/2019 · 1,022 employees
9 Jan 2020
Appointment of Dr Jeremy Farrar as a director · Termination of appointment of David Lindsay Willetts as a director
4 Dec 2019
Director: Daniel Abrams
27 Nov 2019 in Hor
EU funding (€725,810): Human Gonad Developmental Cell Atlas
20 Nov 2019
Director: Nicole Mather
30 Oct 2019
Director: Paul J. R. Schreier · No longer Director (1)
8 Oct 2019
Patent: Animal Models and Therapeutic Molecules
27 Sept 2019
Patent: Method and Apparatus for Analysing a Sample
28 May 2019
Appointment of Mrs Kathy Poole as a director
13 May 2019
Secretary: Nadia Meliti · No longer Secretary (1)
23 Apr 2019
Address
28 Mar 2019
Earnings statement for 30/09/2018 · 1,070 employees
8 Feb 2019
Patent: Oxyphenisatin Acetate, Oxyphenisatin and Bisacodyl for Treating Triple-Negative Breast Cancer
1 Feb 2019 in Hor
EU funding: Genetics of Individuality
28 Jan 2019
Termination of appointment of Timothy James Livett as a director
6 Nov 2018
No longer Director: Jeremy Farrar
25 Jun 2018
Director: James Cuthbert Smith
Year 2018 in Epobase
4 European patent filings: Duplex Sequencing Using Direct Repeat Molecules …
1 May 2018 in Hor
EU funding (€41,704): LIFE LAB - Connecting Communities with the UK's leading Biotechnology and Life Science Hub
11 Apr 2018
Appointment of Professor Dame Kay Elizabeth Davies as a director
Year 2017 in Epobase
9 European patent filings: Hotspots for Chromosomal Rearrangement in Breast and Ovarian Cancers …
20 Dec 2017
Appointment of The Rt Hon Lord David Willetts as a director
18 Dec 2017
Secretary (1) · No longer Director (1)
30 Jun 2017 via Richmond Design & Marketing Ltd.
UK funding (£30,000): Cambridge Autonomous Bus System Feasibility Study
27 Jun 2017
Notification of The Wellcome Trust Limited, as Trustee of the Wellcome Trust as a person with significant control
12 May 2017
Termination of appointment of Timothy James Rink as a director
1 Jan 2017 in Hor
EU funding (€79,028): Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
Year 2016 in Hor
5 EU fundings (€1,635,262): Towards enduring mouse resources and services advancing research into human health and disease …
14 Oct 2016
Patent: Methods Associated with a Database That Stores a Plurality of Reference Genomes
22 Jul 2016
Patent: Nasal Sampling Methods
15 Jul 2016
No longer Director (1)
28 Jun 2016
Annual return made up to 2016-06-28 no member list
11 Mar 2016
Patent: Biallelic Genetic Modification
25 Jan 2016
Auditor's resignation
17 Nov 2015
Patent: In Vitro Production of Expanded Potential Stem Cells
Year 2015 in Hor
8 EU fundings (€273,288): European AIDS Vaccine Initiative 2020 …
20 Aug 2015
Annual return made up to 2015-08-20 no member list · Director's details changed for Professor Rolf Dieter Heuer
2 Apr 2015
Termination of appointment of Elizabeth Lydia Manningham-Buller as a director
10 Feb 2015
No longer Director (1)
4 Feb 2015
Satisfaction of charge 1 in full
6 Jan 2015
Director: Rolf Dieter Heuer
1 Dec 2014 in Hor
EU funding (€200,000): COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe
17 Sept 2014
Patent: Genomic Screening Methods Using RNA-Guided Endonucleases
11 Sept 2014
Patent: Methods of Modulating Platelet Aggregation, Thrombus Formation and Stability, or an Allergy Response
21 Aug 2014 also 20/08/2013, 22/08/2012, 23/08/2011
Annual return made up to 2014-08-20 no member list
20 Aug 2014
Director's details changed for Baroness Elizabeth Lydia Manningham-Buller · Director's details changed for Mr Simon …
2 May 2014
No longer Director (1)
2 Apr 2014
No longer Director (1)
18 Feb 2014
Patent: Nucleic Acid Marker Molecules for Identifying and Detecting Cross Contamination of Nucleic Acid Samples
2 Jan 2014
Address
29 Nov 2013
Director: Jeremy Farrar
1 Nov 2013 via The Automation Partnership (Cambridge) Ltd.
UK funding (£64,559): Personalised iPS Cell Culture System
4 Sept 2013
Patent: HIV-1 Detection
20 May 2013
Patent: Methods and Groups
15 Mar 2013
No longer Director (1)
8 Mar 2013
Word figurative mark: “e!“
27 Jul 2012
No longer Director (1)
8 Feb 2012
No longer Secretary (1)
14 Dec 2011
Patent: P53 Binding Polypeptide
5 Dec 2011
Patent: Compositions and Methods
21 Sept 2011
Patent: Detecting Mutations
11 Jul 2011
Director (1)
1 Jan 2011 via Base4 Innovation Ltd.
UK funding (£227,708): High-speed single molecule detection combining short DNA probes and barcoding bioinformatics for use as a new broad spectrum point-of-care diagnostic
30 Nov 2010
Director (1)
8 Nov 2010
No longer Director (1)
6 Oct 2010
No longer Director (1)
7 Sept 2010
Patent: Cells and Methods for Obtaining Them
31 Aug 2010
Annual return made up to 2010-08-20 no member list · Director's details changed for Mr Simon John Lewis Jeffreys …
27 Aug 2010
Director's details changed for Professor Peter William Jack Rigby
15 Jul 2010
Patent: Cells, Compositions and Methods
19 Apr 2010
No longer Director (1)
2 Dec 2009
Patent: Method for USE in Polynucleotide Sequencing
24 Aug 2009 also 20/08/2008
Annual return made up to 20/08/09
19 May 2009
Director's change of particulars / simon jeffreys / 16/05/2009
13 May 2009
Director (1)
11 Mar 2009
Patent: P53 Binding Polypeptide
2 Mar 2009
No longer Director (1)
19 Feb 2009
Patent: Genetic Variation Associated with Coeliac Disease
18 Dec 2008
Director appointed baroness elizabeth lydia manningham-buller
6 Dec 2007
Particulars of mortgage/charge
14 Sept 2007
Director's particulars changed
23 Aug 2007
Annual return made up to 20/08/07 · Director's particulars changed · Secretary's particulars changed …
2 May 2007 also 23/03/2006, 15/03/2006
New director appointed
10 Apr 2007 also 20/02/2007
Director resigned
21 Aug 2006
Annual return made up to 20/08/06 · Director's particulars changed · Secretary's particulars changed
23 Aug 2005
Annual return made up to 20/08/05 · Director's particulars changed
22 Aug 2005
Address

Mentions

via Companies House in Psc
BO: Genome Research Trading Ltd., GRL Construction Ltd., Genome Research Pensions Trustee Ltd. · Shareholdings: Genome Research Trading Ltd., GRL Construction Ltd., Genome Research Pensions Trustee …

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Genome Research Ltd., Saffron Walden" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close